|
RNGTT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.196000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.747000E-01 |
| Normal-vs-Stage2 |
2.058600E-01 |
| Normal-vs-Stage3 |
2.418800E-01 |
| Normal-vs-Stage4 |
6.531200E-01 |
| Stage1-vs-Stage2 |
8.310100E-02 |
| Stage1-vs-Stage3 |
1.123350E-01 |
| Stage1-vs-Stage4 |
5.065000E-01 |
| Stage2-vs-Stage3 |
7.780200E-01 |
| Stage2-vs-Stage4 |
5.952600E-01 |
| Stage3-vs-Stage4 |
7.326400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.564800E-01 |
| Normal-vs-AfricanAmerican |
1.934180E-01 |
| Normal-vs-Asian |
3.720000E-01 |
| Caucasian-vs-AfricanAmerican |
1.862630E-01 |
| Caucasian-vs-Asian |
4.328600E-01 |
| AfricanAmerican-vs-Asian |
2.351800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.317600E-01 |
| Normal-vs-Female |
1.951710E-02 |
| Male-vs-Female |
4.317500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.037000E-01 |
| Normal-vs-Extreme_Weight |
9.030500E-02 |
| Normal-vs-Obese |
8.386100E-02 |
| Normal-vs-Extreme_Obese |
7.914400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.363400E-01 |
| Normal_Weight-vs-Obese |
5.846500E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.785400E-01 |
| Extreme_Weight-vs-Obese |
2.977400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.044000E-01 |
| Obese-vs-Extreme_Obese |
3.044400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.911370E-01 |
| Normal-vs-Age(41-60Yrs) |
1.843240E-01 |
| Normal-vs-Age(61-80Yrs) |
6.517000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.598700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.733000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.406500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.923740E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.362500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.784470E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.329600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.911800E-01 |
| Normal-VS-Type2 PRCC |
8.990000E-01 |
| Normal-VS-KIRP CIMP |
2.961900E-02 |
| Normal-VS-Unclassified PRCC |
5.351000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.057200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.987000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.835400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.375680E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.833800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.685800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.602800E-01 |
| Normal-vs-N1 |
2.273900E-02 |
| Normal-vs-N2 |
3.240000E-01 |
| N0-vs-N1 |
3.962700E-03 |
| N0-vs-N2 |
9.091800E-01 |
| N1-vs-N2 |
1.637550E-01 |
|
|
